UBS Group’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75K | Sell |
3,438
-14,250
| -81% | -$15.5K | ﹤0.01% | 8000 |
|
|
2025
Q1 | $17.2K | Sell |
17,688
-12,805
| -42% | -$12.4K | ﹤0.01% | 7023 |
|
|
2024
Q4 | $45.1K | Buy |
30,493
+15,014
| +97% | +$22.2K | ﹤0.01% | 6145 |
|
|
2024
Q3 | $32.8K | Buy |
15,479
+5,671
| +58% | +$12K | ﹤0.01% | 5881 |
|
|
2024
Q2 | $23.9K | Buy |
9,808
+9,771
| +26,408% | +$23.8K | ﹤0.01% | 6038 |
|
|
2024
Q1 | $240 | Sell |
37
-963
| -96% | -$6.25K | ﹤0.01% | 7523 |
|
|
2023
Q4 | $3.86K | Hold |
1,000
| – | – | ﹤0.01% | 6715 |
|
|
2023
Q3 | $2.14K | Hold |
1,000
| – | – | ﹤0.01% | 6610 |
|
|
2023
Q2 | $3.05K | Hold |
1,000
| – | – | ﹤0.01% | 6582 |
|
|
2023
Q1 | $2.6K | Sell |
1,000
-448
| -31% | -$1.17K | ﹤0.01% | 7381 |
|
|
2022
Q4 | $2.97K | Sell |
1,448
-1,002
| -41% | -$2.06K | ﹤0.01% | 8394 |
|
|
2022
Q3 | $11K | Sell |
2,450
-1,807
| -42% | -$8.11K | ﹤0.01% | 7194 |
|
|
2022
Q2 | $18K | Buy |
4,257
+2,154
| +102% | +$9.11K | ﹤0.01% | 5974 |
|
|
2022
Q1 | $9K | Sell |
2,103
-7,356
| -78% | -$31.5K | ﹤0.01% | 7492 |
|
|
2021
Q4 | $113K | Buy |
9,459
+7,820
| +477% | +$93.4K | ﹤0.01% | 5134 |
|
|
2021
Q3 | $28K | Buy |
1,639
+639
| +64% | +$10.9K | ﹤0.01% | 5695 |
|
|
2021
Q2 | $17K | Buy |
+1,000
| New | +$17K | ﹤0.01% | 6411 |
|